지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수21
2020
Ⅰ. 서론 ····································································································11. 연구 배경 및 필요성 ····················································································· 12. 선행연구··········································································································· 31) 유해요인조사 개선의 필요성····································································· 32) 유해요인조사 효율적 운영 요건······························································· 43) 유해요인조사 문제점··················································································· 43. 연구의 목적····································································································· 5Ⅱ. 이론적 배경 ······················································································61. 근골격계 유해요인조사의 제도····································································· 61) 근골격계 유해요인조사의 정의································································· 62) 근골격계 유해요인조사의 목적································································· 63) 적용대상········································································································· 64) 위반 시 벌칙 ································································································· 75) 근골격계 유해요인조사의 내용································································· 76) 근골격계 유해요인조사 방법····································································· 87) 근골격계 유해요인조사의 주기································································· 98) 근골격계 유해요인조사의 도구 및 참여자··········································· 10Ⅲ. 연구방법 ····················································································· 111. 연구대상··········································································································· 112. 설문조사 구성································································································· 123. 연구방법··········································································································· 131) 설문응답자의 안전보건분야 종사 경력················································· 142) 설문응답자의 전공····················································································· 153) 설문응답자의 성별····················································································· 164) 설문응답자의 연령····················································································· 175) 설문응답자의 사업장 매출액··································································· 186) 설문응답자의 사업장 근로자 수····························································· 197) 설문응답자의 사업장 노동조합 유무 ····················································· 208) 설문응답자의 직종····················································································· 219) 설문응답자의 업종····················································································· 22Ⅳ. 연구결과 ······················································································· 231. 유해요인조사 방식························································································· 232. 유해요인조사 보고제도의 법적 의무화에 대한 시행율························· 243. 유해요인조사 보고제도의 법적 의무화 장점··········································· 254. 유해요인조사 보고제도의 법적 의무화 문제점 ······································· 265. 유해요인조사 근골격계 질환 예방 및 적절성········································· 276. 유해요인조사 실효성 방안을 위한 발전 방향········································· 287. 유해요인조사 보고제도의 활성화를 위한 지원 제도····························· 298. 유해요인조사 전문조사인력의 자격 요건················································· 309. 유해요인조사 실시율 향상 방안································································· 3110. 유해요인조사 외부기관 위탁 시 사업장 규모별 조사 비용 ··············· 3211. 유해요인조사 후 개선사례 우수사업장의 인센티브 제도 도입 ········· 3612. 유해요인조사 주기의 개선········································································· 3713. 유해요인조사 보고제도의 효율적 운영에 필수적인 요건··················· 3814. 유해요인조사 수행 시 문제점··································································· 3915. 유해요인조사 보고제도의 법적의무화 시 조사 실시율······················· 4016. 유해요인조사 실효성 강화를 위한 발전방향········································· 41Ⅴ. 결론 및 제언 ··············································································· 421. 유해요인조사 현장조사 방식에 대한 분석 결과····································· 422. 유해요인조사 보고제도의 법적의무화에 대한 시행율 ··························· 423. 유해요인조사 보고제도의 법적의무화에 대한 문제점 ··························· 434. 유해요인조사의 주기개선············································································· 435. 조사자의 자격 강화 ······················································································· 446. 유해요인조사 결과보고 제도의 법적의무화 실효성 방안 ····················· 45Ⅵ. 부록 ································································································ 47참고문헌 ······························································································ 52Abstract ································································································ 53
0